Carpal tunnel syndrome associated with interleukin-2 therapy

Cancer

Volumn 77, Issue 6, 1996, Pages 1189-1192

  Puduvalli, Vinay K ^a   Sella, Avishay ^b   Austin, Sara G ^a   Forman, Arthur D ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UTMDACC   (United States)

Author keywords

carpal tunnel syndrome; cytokines; interleukin 2; median nerve; neuropathy; neurotoxicity

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; INTERLEUKIN 2;

ADULT; ARTICLE; CARPAL TUNNEL SYNDROME; CHILL; CLINICAL ARTICLE; DENERVATION; ELECTROMYOGRAPHY; FEMALE; FEVER; HUMAN; HYPESTHESIA; KIDNEY CARCINOMA; MALE; MEDIAN NERVE; MUCOSA INFLAMMATION; NERVE CONDUCTION; PRIORITY JOURNAL; RASH; REPETITIVE STRAIN INJURY; RETROSPECTIVE STUDY; SENSORIMOTOR NEUROPATHY;

ADULT; CARCINOMA, RENAL CELL; CARPAL TUNNEL SYNDROME; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0029916086     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1189::AID-CNCR27>3.0.CO;2-X     Document Type: Article

References (13)

1. Whittington R, Faulds D. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 1993;46:446-514.
2. Clark AG, Holodniy M, Schwartz DH, Katzenstein DA, Merigan TC. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration. J Acquir Immune Defic Syndr 1992;5:52-9.
3. Hayat K, Rodgers S, Bruce L, Rees RC, Chapman K, Reeder S, et al. Malignant melanoma and renal cell carcinoma: immunological and haematological effects of recombinant human interleukin-2. Eur J Cancer 1991;27:1009-14.
4. Davis SD, Berkmen YM, Wang JC. Interleukin-2 therapy for advanced renal cell carcinoma: radiographic evaluation of response and complications. Radiology 1990;177:127-31.
5. Siegel JP, Puri RK. Interleukin-2 toxicity. J Clin Oncol 1991;9:694-704.
6. Heys SD, Mills KL, Eremin O. Bilateral carpal tunnel syndrome associated with interleukin-2 therapy. Postgrad Med J 1992;68:587-8.
7. Phalen GS. The carpal-tunnel syndrome. Clinical evaluation of 598 hands. Clin Orthop 1972;83:29-40.
8. Dawson DM, Hallett M, Millender LH. Entrapment neuropathies. Boston: Little, Brown, and Co., 1990:25-92.
9. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987;107:293-300.
10. Fridman WH, Michon J. Pathophysiology of cytokines. Leuk Res 1990;14:675-7.
11. Stuntz ME, Witte MH, Witte CL, Way DL, Champsi JH, Finley PR. Effect of interleukin-2 on microvascular liquid and protein transport in the rat small intestine. Lymphology 1990;23:149-54.
12. Dahlin LB. Aspects on pathophysiology of nerve entrapments and nerve compression injuries. Neurosurg Clin N Am 1991;2:21-9.
13. Tartour E, Mathiot C, Fridman WH. Current status of interleukin-2 therapy in cancer. Biomed Pharmacother 1992;46:473-84.